postmarketing safety data collection

Free Webinar: Innovative Approaches to Pregnancy Registries

The clinical trial setting precludes data collection about product use and pregnancy, but once a product enters the market, real-world evidence of pregnancy outcomes is essential to providing healthcare guidance for women of childbearing age. Pre-approval planning for a pregnancy registry can ultimately speed approval and positively position your product in the marketplace.

Drawing on her extensive experience and citing real-world examples, Catherine Sigler, PhD, Executive Director, Safety, Epidemiology, Registries, and Risk Management, will explain the benefits of proactive registry design during a free webinar, “Developing Innovative Approaches to Postmarketing Safety Data Collection in Pregnant Women,” on Wednesday, February 24, at 1:30 p.m. EST.


Meetings, Minds and Munchies at DIA 2015

DIA’s slogan, “It’s a Meeting of the Minds” perfectly sums up this banner event for the pharmaceutical and biotech industry. Next week, influential leaders and innovators in life sciences will gather in Washington, D.C., to discuss hot topics, network and learn. We’ll be in the mix and can’t wait to meet, share what’s top of mind, and give you something to munch on.

Subscribe to RSS - postmarketing safety data collection